Koninklijke Philips (NYSE:PHG) Given Average Recommendation of "Moderate Buy" by Analysts

Koninklijke Philips (NYSE:PHG - Get Free Report) has earned an average rating of "Moderate Buy" from the five brokerages that are currently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation, two have issued a buy recommendation and one has given a strong buy recommendation to the company.

PHG has been the topic of several research reports. Sanford C. Bernstein upgraded Koninklijke Philips from a "hold" rating to a "strong-buy" rating in a research note on Tuesday, March 18th. StockNews.com upgraded Koninklijke Philips from a "hold" rating to a "buy" rating in a research note on Saturday, March 8th. UBS Group upgraded shares of Koninklijke Philips from a "neutral" rating to a "buy" rating in a research report on Thursday, February 20th. Finally, BNP Paribas upgraded shares of Koninklijke Philips from a "neutral" rating to an "outperform" rating in a research note on Tuesday, February 25th.

Institutional Inflows and Outflows

Large investors have recently added to or reduced their stakes in the stock. Wealth Enhancement Advisory Services LLC lifted its holdings in shares of Koninklijke Philips by 9.4% in the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 99,003 shares of the technology company's stock worth $2,507,000 after buying an additional 8,526 shares in the last quarter. Forum Financial Management LP lifted its stake in Koninklijke Philips by 18.0% in the 4th quarter. Forum Financial Management LP now owns 11,703 shares of the technology company's stock worth $296,000 after purchasing an additional 1,784 shares in the last quarter. Castlekeep Investment Advisors LLC bought a new position in Koninklijke Philips in the 4th quarter valued at $114,000. Vise Technologies Inc. grew its position in shares of Koninklijke Philips by 50.9% during the 4th quarter. Vise Technologies Inc. now owns 14,224 shares of the technology company's stock valued at $360,000 after purchasing an additional 4,795 shares in the last quarter. Finally, Vident Advisory LLC increased its holdings in shares of Koninklijke Philips by 6.4% in the fourth quarter. Vident Advisory LLC now owns 36,788 shares of the technology company's stock worth $932,000 after purchasing an additional 2,210 shares during the period. Institutional investors own 13.67% of the company's stock.

Remove Ads

Koninklijke Philips Stock Performance

NYSE PHG traded down $0.17 during trading hours on Friday, reaching $25.24. 597,039 shares of the company were exchanged, compared to its average volume of 870,834. The company has a quick ratio of 0.74, a current ratio of 1.23 and a debt-to-equity ratio of 0.59. The stock has a market capitalization of $23.72 billion, a P/E ratio of -30.04, a P/E/G ratio of 0.82 and a beta of 0.78. Koninklijke Philips has a 1 year low of $19.22 and a 1 year high of $32.91. The business's 50 day simple moving average is $26.69 and its 200-day simple moving average is $27.47.

Koninklijke Philips (NYSE:PHG - Get Free Report) last issued its quarterly earnings results on Wednesday, February 19th. The technology company reported $0.54 earnings per share (EPS) for the quarter, missing the consensus estimate of $0.55 by ($0.01). Koninklijke Philips had a positive return on equity of 10.85% and a negative net margin of 3.88%. The company had revenue of $5.38 billion for the quarter, compared to analysts' expectations of $5.10 billion. On average, equities research analysts expect that Koninklijke Philips will post 1.63 earnings per share for the current year.

Koninklijke Philips Cuts Dividend

The business also recently disclosed an annual dividend, which will be paid on Friday, June 6th. Investors of record on Tuesday, May 13th will be paid a dividend of $0.886 per share. The ex-dividend date of this dividend is Tuesday, May 13th. This represents a dividend yield of 2.9%. Koninklijke Philips's payout ratio is -89.29%.

Koninklijke Philips Company Profile

Koninklijke Philips N.V. operates as a health technology company in North America, the Greater China, and internationally. The company operates through Diagnosis & Treatment Businesses, Connected Care Businesses, and Personal Health Businesses segments. It also provides diagnostic imaging solutions, includes magnetic resonance imaging, X-ray systems, and computed tomography (CT) systems and software comprising detector-based spectral CT solutions, as well as molecular and hybrid imaging solutions for nuclear medicine; echography solutions focused on diagnosis, treatment planning and guidance for cardiology, general imaging, obstetrics/gynecology, and point-of-care applications; integrated interventional systems, and interventional diagnostic and therapeutic devices to treat coronary artery and peripheral vascular disease.